Alfredo Pascual headshot
EMAIL: [email protected]
PHONE: 720.213.5971

Alfredo Pascual

Based in Germany, Alfredo specializes in international cannabis markets and regulations, drawing upon his extensive academic background in business and public policy. He founded Transnational Cannabis, a consultancy firm that focused on cannabis regulatory frameworks in Europe and Latin America. Previously, he did business development for ICC Labs with a primary focus on developing expansion opportunities internationally.

Spain still won’t allow local cannabis market, even as exports are occurring

Spain has several medical cannabis licensed producers, and at least one already exports flower to countries such as Germany. But these products remain unavailable to Spanish patients, and a recent government reply to a member of parliament indicates the situation will not change for the time being. In a reply to a question by Josune […]

Read More

New CBD product available under prescription in Peru

A new medical cannabis product is available in Peru, another sign the market is moving in the right direction in terms of business opportunities. Toronto-headquartered Khiron Life Sciences, a company with its main operations in Colombia, said it became the “first company to sell and fill medical cannabis prescriptions through private pharmacies in Peru.” Khiron’s […]

Read More

Dutch government seeks to ease doubts over adult-use cannabis trial

As it seeks to ease public concerns, the Netherlands is evaluating applications to grow marijuana under a pilot program to permit limited cultivation and sales of adult-use cannabis. The selection process involves consulting with mayors of the municipalities where the applicants intend to grow. To clear up any confusion and ease public jitters about the program, […]

Read More

German medical cannabis applications for insurance reach 100,000

Applications for medical cannabis reimbursements with German statutory health insurers (GKV) have hit the 100,000 milestone this year – and 62% were approved, according to data obtained by Marijuana Business Daily. The figure accounts for individual applications submitted since the current program started in early 2017 through mid-2020. This is the first time comprehensive data […]

Read More

Uruguay blames administrative error for cannabis export confusion

Uruguayan authorities are blaming an administrative error for recent communication that medical cannabis shipments from the South American country to Israel would not be able to occur. On Sept. 16, the Israeli health authority notified domestic licensed producers via email that it planned to strengthen quality requirements for medical cannabis imports. The email, viewed by […]

Read More

New Canadian cannabis flower now available in German pharmacies

Germany-based Four 20 Pharma and Northern Green Canada announced their first shipment of non-irradiated medical cannabis flower has reached German pharmacies. The export “from Toronto, Canada to Paderborn, Germany is the part of a larger supply agreement between Four 20 and NGC that will extend into 2021.” Marijuana Business Daily confirmed with a German pharmacy that two […]

Read More

France urged to act on medical cannabis after falling ‘alarmingly behind’

A French parliamentary committee is urging the government to publish a decree needed to initiate a delayed medical cannabis experiment as industry and patient advocates say the country is falling behind in implementation. The appeal was made in a document that was unanimously supported by the parliamentary committee. The document emphasizes the need to establish […]

Read More

Israel to increase import requirements, limiting cannabis export opportunities

The Israeli Ministry of Health informed domestic licensed producers that it is strengthening the quality requirements for medical cannabis imports. In an email addressed to “importers,” Tal Lavy of the pharmaceutical division of the Ministry of Health – the competent national authority under the international drug control treaties – said Israeli authorities will start reviewing […]

Read More

Insurance-covered medical cannabis falls for the first time in Germany

Insurance reimbursements for cannabis in Germany dropped for the first time – on a quarterly basis – since the current medical program started in early 2017, according to new data for the quarter ended June 30, 2020. The reason: Prices fell while the number of prescriptions barely grew. This is consistent with Marijuana Business Daily’s […]

Read More

New medical cannabis product recall in Germany

Cologne, Germany-based Cannamedical is recalling a batch of cannabis flower after contamination above acceptable levels was detected, Marijuana Business Daily has learned. This is at least the third cannabis recall this summer in Germany. Previously, Tilray recalled some cannabis extracts. “On Tuesday, Cannamedical voluntarily started a recall of one batch of flower of our ‘Sativa’ […]

Read More

Czech medical cannabis sales show timid growth despite insurance coverage

Medical cannabis sales in the Czech Republic remain largely insignificant despite health insurance coverage being in place since January 2020, new data shows. Since the beginning of the year, an average of only 5 kilograms (11 pounds) of flower has been sold per month via prescription. June and July were record months with 6 kilograms […]

Read More

More patients receive cannabis prescriptions in Luxembourg

The number of patients who have received cannabis to treat medical conditions in Luxembourg so far this year has surpassed the total for 2019, local newspaper Luxemburger Wort reported. The data was disclosed Thursday by Health Minister Paulette Lenert in a reply to parliament. According to the Luxembourgian newspaper, medical cannabis was prescribed at least […]

Read More